Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Apellis Pharmaceuticals (APLS) stock sees mixed analyst ratings with Wells Fargo upgrading to Overweight while Goldman Sachs downgrades to Sell. High engagement on downgrade posts suggests negative sentiment is currently outweighing positive analyst views.

### About Apellis Pharmaceuticals, Inc. Common Stock
Apellis Pharmaceuticals, Inc. Common Stock (APLS) is a publicly traded stock in the healthcare sector.  
Apellis Pharmaceuticals, Inc. Common Stock uses the ticker $APLS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Apellis Pharmaceuticals, Inc. Common Stock (APLS) trading volume is up XXXXXX% from the previous week.
- Apellis Pharmaceuticals, Inc. Common Stock (APLS) market cap is up XXXXX% from the previous month.
- Apellis Pharmaceuticals, Inc. Common Stock (APLS) creators is up XXXXX% from the previous week.
- Apellis Pharmaceuticals, Inc. Common Stock (APLS) engagements is up XXXX% from the previous week.
- Apellis Pharmaceuticals, Inc. Common Stock (APLS) mentions is up XXXXX% from the previous week.
- Apellis Pharmaceuticals, Inc. Common Stock (APLS) posts created is up XXXXX% from the previous week.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$apls/time-series/close.tsv)  
The stock price is experiencing downward pressure due to a recent downgrade by Goldman Sachs, despite a positive upgrade from Wells Fargo. High engagement on downgrade-related posts suggests this sentiment is currently outweighing positive analyst views.  

24-Hour: -XXXX%
7-Day: XXXXX%
30-Day: XXXXX%

1-Year High: $XXXXX on 2025-01-07  
1-Year Low: $XXXXX on 2025-05-15  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$apls/time-series/alt_rank.tsv)  
Apellis Pharmaceuticals, Inc. Common Stock (APLS) is currently AltRank #1,301 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXXXX -XXX  
X Month: XXXXX -XX  
X Months: XXXXX +255  
X Year: XXXXX +1,011  
1-Year High: XXXXX on 2025-06-28  
1-Year Low: XX on 2025-01-18  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$apls/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX no change  
X Month: XX -XX  
X Months: XX -X  
X Year: XX -XX  
1-Year High: XX on 2025-10-15  
1-Year Low: XX on 2025-09-05  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$apls/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXX  
X Week: XXXXX +77%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-02-28  
1-Year Low: XXX on 2025-12-02  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$apls/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XXX +47%  
X Month: XXX +7.50%  
X Months: XXXXX +17%  
X Year: XXXXX +34%  
1-Year High: XXX on 2025-01-02  
1-Year Low: XX on 2025-10-11  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$apls/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Apellis Pharmaceuticals, Inc. Common Stock (APLS) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX +62%  
X Month: XXX -XXXX%  
X Months: XXXXX +104%  
X Year: XXXXX +82%  
1-Year High: XXX on 2025-06-29  
1-Year Low: XX on 2025-09-14  

The most influential creators that mention Apellis Pharmaceuticals, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | X     | XXX         |
| [@MattBiotech](/creator/twitter/MattBiotech)         | X    | XXXXX     | X     | XX          |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XX          |
| [@Evie71425](/creator/twitter/Evie71425)             | X    | XX        | X     | XX          |
| [@seedytx19](/creator/twitter/seedytx19)             | X    | XXXXX     | X     | XX          |
| [@linhnguyen64143](/creator/twitter/linhnguyen64143) | X    | XX        | X     | XX          |
| [@James7Dolph](/creator/twitter/James7Dolph)         | X    | XX        | X     | X           |
| [@Skwld69988](/creator/twitter/Skwld69988)           | X    | X         | X     | X           |
| [@FrenzyCapital](/creator/twitter/FrenzyCapital)     | X    | XXXXX     | X     | X           |
| [@HenriettaBrid19](/creator/twitter/HenriettaBrid19) | XX   | XXX       | X     | X           |

[View More](/list/creators/$apls/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$apls/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2025-04-13  
1-Year Low: X% on 2025-09-09  

Most Supportive Themes:
- Wells Fargo Upgrade: (15%) Wells Fargo has upgraded Apellis Pharmaceuticals, Inc. Common Stock (APLS) to Overweight, signaling a positive outlook from the financial institution.
  
Most Critical Themes:
- Goldman Sachs Downgrade: (60%) Goldman Sachs has downgraded Apellis Pharmaceuticals, Inc. Common Stock (APLS) to Sell, indicating a negative sentiment from the investment bank.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$apls/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXX%  
X Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%  
X Month: XXXXX% +0.017%  
X Months: XXXXX% +0.012%  
X Year: XXXXX% -XXXXX%  
1-Year High: XXXXX% on 2025-01-02  
1-Year Low: XXXXXX% on 2025-10-11  
  
  
### Market Dominance: XXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$apls/time-series/market_dominance.tsv)  
Current Value: XXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2024-12-23  
1-Year Low: XXXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$apls/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$18%  
X Month: $XXXXXXXXXXXXX +$23%  
X Months: $XXXXXXXXXXXXX +$24%  
X Year: $XXXXXXXXXXXXX -$31%  
1-Year High: $XXXXXXXXXXXXX on 2025-01-07  
1-Year Low: $XXXXXXXXXXXXX on 2025-05-15  

### Top Apellis Pharmaceuticals, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$APLS $ARB Guys Don't miss the next move in a few hours. =-"  
[X Link](https://x.com/Skwld69988/status/1998421197260992671) [@Skwld69988](/creator/x/Skwld69988) 2025-12-09T15:55Z X followers, XX engagements


"I think it's time for a move back to .40+ and higher @ProfitGrand You nailed it last time. Dejavu $PLTR $META $MNTS $MU $KXIN $PYPL $LRE $IONQ $APLS $GME $AI $BB $CHPT $AAPL $ROKU $DJT $AMC $TSLA $AMD $NVDA $TLRY $AMZN $NU $NUVA $RIVN $MLGO $KOSS $MAXN $HOLO $CERO $QLGN $GDHG $LGHL $MAXN $ZAPP $BENF $STAF $BSFC"  
[X Link](https://x.com/TradershubNinja/status/1998108818631196893) [@TradershubNinja](/creator/x/TradershubNinja) 2025-12-08T19:14Z 4011 followers, XXX engagements


""With drug candidates targeting pathway-specific initiation (anti-C1s anti-MASP2) amplification (FD and FB inh) and effector ft (C5aR1 inh) in late-stage devpt we finally enter a new era in complement-modulating therapies" $IFRX $APLS"  
[X Link](https://x.com/giger1964/status/1998009248018547182) [@giger1964](/creator/x/giger1964) 2025-12-08T12:38Z XX followers, XXX engagements


"$APLS Target price for Upcoming week💯💰👇"  
[X Link](https://x.com/henkletrade/status/1997942117503791223) [@henkletrade](/creator/x/henkletrade) 2025-12-08T08:11Z XX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Apellis Pharmaceuticals (APLS) stock sees mixed analyst ratings with Wells Fargo upgrading to Overweight while Goldman Sachs downgrades to Sell. High engagement on downgrade posts suggests negative sentiment is currently outweighing positive analyst views.

About Apellis Pharmaceuticals, Inc. Common Stock

Apellis Pharmaceuticals, Inc. Common Stock (APLS) is a publicly traded stock in the healthcare sector.
Apellis Pharmaceuticals, Inc. Common Stock uses the ticker $APLS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Apellis Pharmaceuticals, Inc. Common Stock (APLS) trading volume is up XXXXXX% from the previous week.
  • Apellis Pharmaceuticals, Inc. Common Stock (APLS) market cap is up XXXXX% from the previous month.
  • Apellis Pharmaceuticals, Inc. Common Stock (APLS) creators is up XXXXX% from the previous week.
  • Apellis Pharmaceuticals, Inc. Common Stock (APLS) engagements is up XXXX% from the previous week.
  • Apellis Pharmaceuticals, Inc. Common Stock (APLS) mentions is up XXXXX% from the previous week.
  • Apellis Pharmaceuticals, Inc. Common Stock (APLS) posts created is up XXXXX% from the previous week.

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is experiencing downward pressure due to a recent downgrade by Goldman Sachs, despite a positive upgrade from Wells Fargo. High engagement on downgrade-related posts suggests this sentiment is currently outweighing positive analyst views.

24-Hour: -XXXX% 7-Day: XXXXX% 30-Day: XXXXX%

1-Year High: $XXXXX on 2025-01-07
1-Year Low: $XXXXX on 2025-05-15

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Apellis Pharmaceuticals, Inc. Common Stock (APLS) is currently AltRank #1,301 based on combined combined social and market metrics Daily Average: XXX
X Week: XXXXX -XXX
X Month: XXXXX -XX
X Months: XXXXX +255
X Year: XXXXX +1,011
1-Year High: XXXXX on 2025-06-28
1-Year Low: XX on 2025-01-18

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX no change
X Month: XX -XX
X Months: XX -X
X Year: XX -XX
1-Year High: XX on 2025-10-15
1-Year Low: XX on 2025-09-05

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXX +77%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-02-28
1-Year Low: XXX on 2025-12-02

Engagements by network (24h): X: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX +47%
X Month: XXX +7.50%
X Months: XXXXX +17%
X Year: XXXXX +34%
1-Year High: XXX on 2025-01-02
1-Year Low: XX on 2025-10-11

Mentions by network (24h): X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Apellis Pharmaceuticals, Inc. Common Stock (APLS) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX +62%
X Month: XXX -XXXX%
X Months: XXXXX +104%
X Year: XXXXX +82%
1-Year High: XXX on 2025-06-29
1-Year Low: XX on 2025-09-14

The most influential creators that mention Apellis Pharmaceuticals, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@semodough X XXXXXX X XXX
@MattBiotech X XXXXX X XX
@NightOwlBiotech X XXXXX X XX
@Evie71425 X XX X XX
@seedytx19 X XXXXX X XX
@linhnguyen64143 X XX X XX
@James7Dolph X XX X X
@Skwld69988 X X X X
@FrenzyCapital X XXXXX X X
@HenriettaBrid19 XX XXX X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-04-13
1-Year Low: X% on 2025-09-09

Most Supportive Themes:

  • Wells Fargo Upgrade: (15%) Wells Fargo has upgraded Apellis Pharmaceuticals, Inc. Common Stock (APLS) to Overweight, signaling a positive outlook from the financial institution.

Most Critical Themes:

  • Goldman Sachs Downgrade: (60%) Goldman Sachs has downgraded Apellis Pharmaceuticals, Inc. Common Stock (APLS) to Sell, indicating a negative sentiment from the investment bank.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXX%
X Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
X Month: XXXXX% +0.017%
X Months: XXXXX% +0.012%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-10-11

Market Dominance: XXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-12-23
1-Year Low: XXXXXX% on 2025-12-09

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$18%
X Month: $XXXXXXXXXXXXX +$23%
X Months: $XXXXXXXXXXXXX +$24%
X Year: $XXXXXXXXXXXXX -$31%
1-Year High: $XXXXXXXXXXXXX on 2025-01-07
1-Year Low: $XXXXXXXXXXXXX on 2025-05-15

Top Apellis Pharmaceuticals, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$APLS $ARB Guys Don't miss the next move in a few hours. =-"
X Link @Skwld69988 2025-12-09T15:55Z X followers, XX engagements

"I think it's time for a move back to .40+ and higher @ProfitGrand You nailed it last time. Dejavu $PLTR $META $MNTS $MU $KXIN $PYPL $LRE $IONQ $APLS $GME $AI $BB $CHPT $AAPL $ROKU $DJT $AMC $TSLA $AMD $NVDA $TLRY $AMZN $NU $NUVA $RIVN $MLGO $KOSS $MAXN $HOLO $CERO $QLGN $GDHG $LGHL $MAXN $ZAPP $BENF $STAF $BSFC"
X Link @TradershubNinja 2025-12-08T19:14Z 4011 followers, XXX engagements

""With drug candidates targeting pathway-specific initiation (anti-C1s anti-MASP2) amplification (FD and FB inh) and effector ft (C5aR1 inh) in late-stage devpt we finally enter a new era in complement-modulating therapies" $IFRX $APLS"
X Link @giger1964 2025-12-08T12:38Z XX followers, XXX engagements

"$APLS Target price for Upcoming week💯💰👇"
X Link @henkletrade 2025-12-08T08:11Z XX followers, XX engagements

Apellis Pharmaceuticals, Inc. Common Stock (APLS)
/topic/$apls